Newron Pharmaceuticals S.p.A. (NWRN.SW)

CHF 8.0

(11.73%)

Inventory Summary of Newron Pharmaceuticals S.p.A.

  • Newron Pharmaceuticals S.p.A.'s latest annual inventory in 2023 was 1.00 EUR , down 0.0% from previous year.
  • Newron Pharmaceuticals S.p.A.'s latest quarterly inventory in 2024 Q2 was 2.44 Million EUR , down 0.0% from previous quarter.
  • Newron Pharmaceuticals S.p.A. reported annual inventory of 1.00 EUR in 2022, down 0.0% from previous year.
  • Newron Pharmaceuticals S.p.A. reported annual inventory of - EUR in 2021, down 0.0% from previous year.
  • Newron Pharmaceuticals S.p.A. reported quarterly inventory of 2.00 EUR for 2023 Q2, down 0.0% from previous quarter.
  • Newron Pharmaceuticals S.p.A. reported quarterly inventory of 1.00 EUR for 2023 FY, down 0.0% from previous quarter.

Annual Inventory Chart of Newron Pharmaceuticals S.p.A. (2023 - 2005)

Historical Annual Inventory of Newron Pharmaceuticals S.p.A. (2023 - 2005)

Year Inventory Inventory Growth
2023 1.00 EUR 0.0%
2022 1.00 EUR 0.0%
2021 - EUR 0.0%
2020 - EUR -100.0%
2019 1.00 EUR 0.0%
2018 1.00 EUR -99.98%
2017 5000.00 EUR 0.0%
2016 5000.00 EUR -86.84%
2015 38 Thousand EUR -62.75%
2014 102 Thousand EUR -66.11%
2013 301 Thousand EUR 29.18%
2012 233 Thousand EUR -5.28%
2011 246 Thousand EUR -37.88%
2010 396 Thousand EUR 4.21%
2009 380 Thousand EUR -42.16%
2008 657 Thousand EUR 25.62%
2007 523 Thousand EUR -61.12%
2006 1.34 Million EUR 82.0%
2005 739 Thousand EUR 0.0%

Peer Inventory Comparison of Newron Pharmaceuticals S.p.A.

Name Inventory Inventory Difference
Addex Therapeutics Ltd - CHF -Infinity%
BB Biotech AG -2.63 Billion CHF 100.0%
Basilea Pharmaceutica AG 26.41 Million CHF 100.0%
Evolva Holding SA - CHF -Infinity%
Idorsia Ltd 59.14 Million CHF 100.0%
Kuros Biosciences AG 4.85 Million CHF 100.0%
Molecular Partners AG - CHF -Infinity%
Relief Therapeutics Holding AG 557 Thousand CHF 100.0%
Santhera Pharmaceuticals Holding AG 1.81 Million CHF 100.0%